Phosphodiesterase 4 inhibitors
US7700631B2 · kind B2 · utility
2Cited by
42References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 20, 2006 |
| Grant date | Apr 20, 2010 |
| Priority date | — |
| Expiry date | Apr 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
PDE4 inhibition is achieved by novel nitroxide compounds, e.g., N-substituted aniline and diphenylamine analogs. The compounds of the present invention are of Formulas I-III:wherein A, B, D, R1, R2, R3, R7, R8, R9, R10 and R6 are as defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.